EP3256095C0 - Utilisation d'une association de taurine ou d'un dérivé de celle-ci, de biotine, de vitamin c, de zinc ou d'une de ses sels et d'extrait de raisin pour lutter contre les cheveux fins - Google Patents
Utilisation d'une association de taurine ou d'un dérivé de celle-ci, de biotine, de vitamin c, de zinc ou d'une de ses sels et d'extrait de raisin pour lutter contre les cheveux finsInfo
- Publication number
- EP3256095C0 EP3256095C0 EP16703994.0A EP16703994A EP3256095C0 EP 3256095 C0 EP3256095 C0 EP 3256095C0 EP 16703994 A EP16703994 A EP 16703994A EP 3256095 C0 EP3256095 C0 EP 3256095C0
- Authority
- EP
- European Patent Office
- Prior art keywords
- taurine
- biotin
- vitamin
- derivative
- zinc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 title 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title 1
- 229960005070 ascorbic acid Drugs 0.000 title 1
- 229960002685 biotin Drugs 0.000 title 1
- 235000020958 biotin Nutrition 0.000 title 1
- 239000011616 biotin Substances 0.000 title 1
- 229940038487 grape extract Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 229960003080 taurine Drugs 0.000 title 1
- 239000011701 zinc Substances 0.000 title 1
- 229910052725 zinc Inorganic materials 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/002—Preparations for repairing the hair, e.g. hair cure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1551201A FR3032612B1 (fr) | 2015-02-13 | 2015-02-13 | Utilisation d'une association de taurine ou un de ses derives, de biotine et d'extrait de raisins pour lutter contre les cheveux fins |
PCT/EP2016/052960 WO2016128532A1 (fr) | 2015-02-13 | 2016-02-12 | Utilisation d'une association de taurine ou d'un dérivé de celle-ci, de biotine et d'extrait de raisin pour lutter contre les cheveux fins |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3256095A1 EP3256095A1 (fr) | 2017-12-20 |
EP3256095B1 EP3256095B1 (fr) | 2023-06-28 |
EP3256095C0 true EP3256095C0 (fr) | 2023-06-28 |
Family
ID=52829149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16703994.0A Active EP3256095B1 (fr) | 2015-02-13 | 2016-02-12 | Utilisation d'une association de taurine ou d'un dérivé de celle-ci, de biotine, de vitamin c, de zinc ou d'une de ses sels et d'extrait de raisin pour lutter contre les cheveux fins |
Country Status (8)
Country | Link |
---|---|
US (1) | US20180036214A1 (fr) |
EP (1) | EP3256095B1 (fr) |
CN (1) | CN107205919A (fr) |
BR (1) | BR112017017333A2 (fr) |
CA (1) | CA2975198A1 (fr) |
ES (1) | ES2949985T3 (fr) |
FR (1) | FR3032612B1 (fr) |
WO (1) | WO2016128532A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3235490A1 (fr) * | 2016-04-18 | 2017-10-25 | L'Oréal | Composition pour améliorer la qualité des cheveux |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002097116A (ja) * | 2000-09-19 | 2002-04-02 | Shiseido Co Ltd | 細胞賦活剤 |
CN1662229B (zh) * | 2002-06-21 | 2010-05-26 | 奥里尔股份有限公司 | 牛磺酸和/或亚牛磺酸在制备治疗秃头症的药物中的应用 |
CA2498199C (fr) * | 2002-09-09 | 2012-01-17 | Nestec S.A. | Composition a administration orale permettant d'ameliorer la qualite des cheveux ou du pelage |
FR2861594B1 (fr) * | 2003-11-03 | 2006-01-20 | Baudry Jacquet | Composition contenant un extrait de the vert et de la vitamine c |
EP1932509A1 (fr) * | 2006-12-14 | 2008-06-18 | L'oreal | Utilisation orale d'au moins un acide gras monoinsaturé pour améliorer la chevelure |
FR2953722B1 (fr) * | 2009-12-16 | 2012-03-09 | Expanscience Lab | Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles |
FR2996128B1 (fr) * | 2012-09-28 | 2015-01-02 | Inneov Lab | Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles. |
-
2015
- 2015-02-13 FR FR1551201A patent/FR3032612B1/fr active Active
-
2016
- 2016-02-12 EP EP16703994.0A patent/EP3256095B1/fr active Active
- 2016-02-12 ES ES16703994T patent/ES2949985T3/es active Active
- 2016-02-12 BR BR112017017333A patent/BR112017017333A2/pt not_active Application Discontinuation
- 2016-02-12 WO PCT/EP2016/052960 patent/WO2016128532A1/fr active Application Filing
- 2016-02-12 US US15/550,546 patent/US20180036214A1/en not_active Abandoned
- 2016-02-12 CA CA2975198A patent/CA2975198A1/fr not_active Abandoned
- 2016-02-12 CN CN201680009989.XA patent/CN107205919A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3256095B1 (fr) | 2023-06-28 |
WO2016128532A1 (fr) | 2016-08-18 |
FR3032612B1 (fr) | 2017-02-24 |
US20180036214A1 (en) | 2018-02-08 |
ES2949985T3 (es) | 2023-10-04 |
EP3256095A1 (fr) | 2017-12-20 |
CA2975198A1 (fr) | 2016-08-18 |
FR3032612A1 (fr) | 2016-08-19 |
BR112017017333A2 (pt) | 2018-04-03 |
CN107205919A (zh) | 2017-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190053T1 (hr) | Derivati tetrahidronaftalena koji inhibiraju protein mcl-1 | |
SG11202004341YA (en) | Cosmetic mask | |
HK1252677A1 (zh) | 噴霧型防曬化妝品 | |
EP3354156A4 (fr) | Nécessaire de masque facial | |
SG11201702819YA (en) | Skin cosmetic | |
GB201616070D0 (en) | Skin cosmetic | |
HUE055684T2 (hu) | 4-bora-3a,4a-diaza-s-indacének alkalmazása biztonsági célokra | |
SG11201704497PA (en) | Agent for hair deforming treatment | |
SG11201704499WA (en) | Agent for hair deforming treatment | |
SG10201913607WA (en) | Moisturizing topical preparation | |
HK1258583A1 (zh) | 皮膚美白化妝品 | |
EP3253766A4 (fr) | Composés et procédés pour prévenir ou traiter la mort de cellules capillaires sensorielles | |
SG11201704504PA (en) | Agent for hair deforming treatment | |
SG11201602573RA (en) | Skin cosmetic composition | |
HK1254690A1 (zh) | 防曬化妝品 | |
EP3311790A4 (fr) | Agent de traitement capillaire | |
SG11201704493UA (en) | Agent for hair deforming treatment | |
EP3205345A4 (fr) | Composition pour prévenir la chute des cheveux ou stimuler la pousse des cheveux comprenant un extrait d'artemisia umbelliformis | |
HK1252538A1 (zh) | 防曬化妝品 | |
EP3256095C0 (fr) | Utilisation d'une association de taurine ou d'un dérivé de celle-ci, de biotine, de vitamin c, de zinc ou d'une de ses sels et d'extrait de raisin pour lutter contre les cheveux fins | |
HK1244684A1 (zh) | 角蛋白處理 | |
IL251862A0 (en) | Combined treatment to delay hair loss | |
GB201705352D0 (en) | Cosmetic Mask | |
EP3145507A4 (fr) | Analogues d'aza-éllipticine, procédés de synthèse et procédés de traitement | |
GB201513556D0 (en) | Patch for person's skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170811 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20190712 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20230120 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1582097 Country of ref document: AT Kind code of ref document: T Effective date: 20230715 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016080598 Country of ref document: DE |
|
U01 | Request for unitary effect filed |
Effective date: 20230712 |
|
U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20230828 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2949985 Country of ref document: ES Kind code of ref document: T3 Effective date: 20231004 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230928 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230628 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230628 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230929 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230628 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231221 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231028 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230628 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230628 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230628 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231028 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230628 |
|
U20 | Renewal fee paid [unitary effect] |
Year of fee payment: 9 Effective date: 20240108 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230628 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240307 Year of fee payment: 9 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |